tailieunhanh - XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance

DNA repair pathways are used by cancer cells to overcome many standard anticancer treatments, causing therapy resistance. Here, we investigated the role of XRCC4-like factor (XLF), a core member of the non-homologous end joining (NHEJ) repair pathway, in chemoresistance in hepatocellular carcinoma (HCC). | XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN